PodcastsBusinessThe Finimize Daily Brief

The Finimize Daily Brief

Finimize
The Finimize Daily Brief
Latest episode

455 episodes

  • The Finimize Daily Brief

    Anthropic Is Spending Billions On Chips And Cloud, And Private Equity Deals Are Way Down This Year

    08/04/2026 | 5 mins.
    Claude creator Anthropic is coughing up billions on chips and cloud, and private equity deals are way down so far this year.
    Try Finimize Pro
  • The Finimize Daily Brief

    With No End In Sight, The War Is Causing Market Chaos, And Amazon’s Eyeing A Deal With Satellite Operator Globalstar

    03/04/2026 | 5 mins.
    The US president’s address offered no clear pathway to ending the hostilities, five weeks after the conflict began – and with satellite internet shaping up to be the next mission for tech titans, Amazon is looking to make some strategic deals.
    Today’s stories:
    Investor Uncertainty Escalated With No Clear Timeline To Resolve The War
    Amazon Is Looking To Buy Globalstar As The Space Race Heats Up
    Try Finimize Pro
  • The Finimize Daily Brief

    OpenAI’s Latest Round Of Funding Is Practically Mythical, And Warren Buffett Still Loves Apple – Just Not That Much

    02/04/2026 | 5 mins.
    The unicorn paddock is starting to get crowded – OpenAI, SpaceX, Anthropic, and others are eyeing an escape to the public market – while Berkshire Hathaway’s still heavily into Apple, but it’s cautious about tech exposure.
    Today’s stories:
    OpenAI’s Fantastical Valuation Is Fueling Speculation That An IPO Is Coming
    Buffett's Apple Regret Is Real – Just Not Enough To Buy Back In
    Try Finimize Pro
  • The Finimize Daily Brief

    The Eurozone Just Reported A Big Bump Up In Inflation, And Chipmakers Saw Their Luck Run Out

    01/04/2026 | 5 mins.
    The eurozone was the first big economy to release its consumer price index for March (next up: the US and China), while it looks like chipmakers’ luck is running out.
    Today’s stories:
    Eurozone Inflation Just Sped Up – And Other Economies Are Set To Follow
    Memory Chipmakers Just Had Their Worst Month Since 2005
    Try Finimize Pro
  • The Finimize Daily Brief

    Eli Lilly’s Got A Sparkling New AI Biopharma Deal, And European Inflation Fears Are Rising

    31/03/2026 | 5 mins.
    The US maker of Zepbound just signed a $2.75 billion deal with Hong Kong-based Insilico Medicine for an AI-developed drug – while eurozone consumers and businesses say they expect prices to rise… and that suggests they will.
    Today’s stories:
    Eli Lilly’s Got A Sparkling New AI Biopharma Deal
    Inflation Fears Are Brewing Across Europe
    Try Finimize Pro

More Business podcasts

About The Finimize Daily Brief

The Finimize Daily Brief. Get everything you need to know about the day's biggest financial stories and trends, in five minutes or less, plus a regular Q+A with our world-class team of analysts.
Podcast website

Listen to The Finimize Daily Brief, Better With Money and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

The Finimize Daily Brief: Podcasts in Family